Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07797036
What this trial is testing

Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus

Who this might be right for
Gestational Diabetes Mellitus (GDM)Metabolic Syndrome
University of Massachusetts, Worcester 226
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Not applicableStudy completedNCT01043445
What this trial is testing

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

Who this might be right for
Type 2 Diabetes
Glostrup University Hospital, Copenhagen 8
Post-approval studies (Phase 4)Not Yet RecruitingNCT07027969
What this trial is testing

Metabolic Surgery for Atrial Fibrillation Elimination

Who this might be right for
Atrial FibrillationObesity and Obesity-related Medical Conditions
Ali Aminian 100
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Large-scale testing (Phase 3)Study completedNCT03987919
What this trial is testing

Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 1,879
Early research (Phase 1)UnknownNCT06520540
What this trial is testing

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Who this might be right for
Glucagon-Like Peptide-1 Receptor Agonists
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Post-approval studies (Phase 4)Study completedNCT02589626
What this trial is testing

Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 65
Large-scale testing (Phase 3)Study completedNCT00763815
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Who this might be right for
Diabetes Mellitus Type 2
Sanofi 484
Not applicableUnknownNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Large-scale testing (Phase 3)Study completedNCT01847313
What this trial is testing

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Karl Neff 20
Post-approval studies (Phase 4)Ended earlyNCT00799435
What this trial is testing

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

Who this might be right for
Diabetes Mellitus, Type 2Heart Failure, Diastolic
Baylor College of Medicine 2
Early research (Phase 1)Study completedNCT00530309
What this trial is testing

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 40
Testing effectiveness (Phase 2)UnknownNCT02829502
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

Who this might be right for
Ischemic Stroke
Christina Kruuse 30
Large-scale testing (Phase 3)Study completedNCT01554618
What this trial is testing

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

Who this might be right for
Children and Adolescent With Type 2 Diabetes
AstraZeneca 84
Not applicableStudy completedNCT04788836
What this trial is testing

How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)

Who this might be right for
Food PreferencesObesity
Lia Bally 61
Not applicableEnrolling By InvitationNCT06581120
What this trial is testing

GLP_1 RA Ultrasound Study

Who this might be right for
Glucagon Like Peptide-1 (GLP-1Delayed Gastric EmptyingRisk of Aspiration+2 more
Children's Hospital Medical Center, Cincinnati 100
Post-approval studies (Phase 4)Looking for participantsNCT07513168
What this trial is testing

Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

Who this might be right for
ObesityWeight ReductionCardiometabolic Risk Factors
Asian Institute Of Medical Sciences 60
Early research (Phase 1)Study completedNCT03341013
What this trial is testing

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 24
Not applicableNot Yet RecruitingNCT07811895
What this trial is testing

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Who this might be right for
TirzepatideFrozen Embryo TransferObesity
RenJi Hospital 1,510
Next Page